Mimedx Group Stock Alpha and Beta Analysis

MDXG Stock  USD 9.20  0.02  0.22%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as MiMedx Group. It also helps investors analyze the systematic and unsystematic risks associated with investing in MiMedx over a specified time horizon. Remember, high MiMedx's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to MiMedx's market risk premium analysis include:
Beta
0.32
Alpha
0.54
Risk
4.32
Sharpe Ratio
0.14
Expected Return
0.61
Please note that although MiMedx alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, MiMedx did 0.54  better than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of MiMedx Group stock's relative risk over its benchmark. MiMedx Group has a beta of 0.32  . As returns on the market increase, MiMedx's returns are expected to increase less than the market. However, during the bear market, the loss of holding MiMedx is expected to be smaller as well. At this time, MiMedx's Enterprise Value Over EBITDA is most likely to increase significantly in the upcoming years. The MiMedx's current Enterprise Value Multiple is estimated to increase to 25.60, while Price Book Value Ratio is projected to decrease to 6.80.

Enterprise Value

1.04 Billion

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out MiMedx Backtesting, MiMedx Valuation, MiMedx Correlation, MiMedx Hype Analysis, MiMedx Volatility, MiMedx History and analyze MiMedx Performance.

MiMedx Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. MiMedx market risk premium is the additional return an investor will receive from holding MiMedx long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in MiMedx. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate MiMedx's performance over market.
α0.54   β0.32

MiMedx expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of MiMedx's Buy-and-hold return. Our buy-and-hold chart shows how MiMedx performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

MiMedx Market Price Analysis

Market price analysis indicators help investors to evaluate how MiMedx stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading MiMedx shares will generate the highest return on investment. By understating and applying MiMedx stock market price indicators, traders can identify MiMedx position entry and exit signals to maximize returns.

MiMedx Return and Market Media

The median price of MiMedx for the period between Tue, Aug 27, 2024 and Mon, Nov 25, 2024 is 6.18 with a coefficient of variation of 16.35. The daily time series for the period is distributed with a sample standard deviation of 1.07, arithmetic mean of 6.57, and mean deviation of 0.82. The Stock received a lot of media exposure during the period.
 Price Growth (%)  
       Timeline  
1
Insider Trading
09/13/2024
2
MiMedx Group, Inc. Shares Sold by Richmond Brothers Inc. - MarketBeat
09/19/2024
3
MiMedx Group Q3 2024 Earnings Preview
10/29/2024
4
MiMedx Group Non-GAAP EPS of 0.07 beats by 0.03, revenue of 84M beats by 0.98M
10/30/2024
5
Microsoft, Meta among Thursdays afternoon market cap stock movers
10/31/2024
6
MiMedx Group, Inc. Q3 2024 Earnings Call Transcript
11/01/2024
7
Can MiMedx Climb 77.92 percent to Reach the Level Wall Street Analysts Expect
11/04/2024
8
Vanguard Group Incs Strategic Acquisition in MiMedx Group Inc
11/05/2024
9
MiMedx Group, Inc. Given Average Rating of Buy by Brokerages
11/12/2024
10
MiMedx Is a Great Choice for Trend Investors, Heres Why
11/15/2024
11
We Ran A Stock Scan For Earnings Growth And MiMedx Group Passed With Ease
11/21/2024

About MiMedx Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including MiMedx or other stocks. Alpha measures the amount that position in MiMedx Group has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2021 2022 2023 2024 (projected)
Payables Turnover5.865.726.043.26
Days Of Inventory On Hand96.0499.59140.44135.29

MiMedx Upcoming Company Events

As portrayed in its financial statements, the presentation of MiMedx's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, MiMedx's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of MiMedx's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of MiMedx. Please utilize our Beneish M Score to check the likelihood of MiMedx's management manipulating its earnings.
27th of February 2024
Upcoming Quarterly Report
View
7th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
27th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Build Portfolio with MiMedx

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether MiMedx Group is a strong investment it is important to analyze MiMedx's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact MiMedx's future performance. For an informed investment choice regarding MiMedx Stock, refer to the following important reports:
MiMedx technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of MiMedx technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of MiMedx trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...